The Science of Social Media

The Naked Scientists Podcast

Dr Chris Smith

Science Radio, Engineering, Naked Scientists, Natural Sciences, Technology, Life Sciences, Health & Fitness, Medicine, Science

4.6 • 957 Ratings

🗓️ 19 December 2017

⏱️ 59 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Social media use is more common than ever, with over 2 billion of us signed up, but do we know what it's doing to our brains? We're exploring how this exploding trend is influencing our opinions and our wellbeing, and also how it could be used as a tool to diagnose mental illness. Plus, news of a breakthrough in Huntington's Disease research and a celebration of 50 years since the spooky radio signals that changed astronomy forever.Find more episodes and transcripts at www.nakedscientists.com Like this podcast? Please help us by supporting the Naked Scientists

Transcript

Click on a timestamp to play from that location

0:00.0	I have you loud and clear.
0:03.2	Hello.
0:04.2	Hello.
0:05.2	Welcome.
0:06.2	Science.
0:09.2	And that is the same physics, medicine, nature, or space, time, brain, life, the universe.
0:15.0	This week's social media,
0:18.0	or should that more accurately be anti social media,
0:21.0	we're exploring how this exploding trend is influencing our opinions,
0:25.0	might be addictive for some, but might also provide us with new ways to spot people with
0:29.7	mental and other illnesses much faster than a doctor can.
0:33.0	Plus in the news a breakthrough in treating the brain condition Huntington's
0:37.1	disease. A dinosaur parasite is found fossilized in amber and it's 50 years
0:41.8	since scientists first heard spooky radio signals from deep
0:44.8	space. But what were they? I'm Georgia Mills. I'm Chris Smith and this is The Naked Scientists.
0:50.1	The Naked Scientists podcast is powered by UKfast.co.uk.
0:55.0	First our top story this week, a DNA-based drug that can penetrate brain cells might
1:06.6	be about to revolutionize the treatment of the degenerative condition
1:09.7	Huntington's disease. The success of a small initial trial of the agent, currently called IONAS
1:15.4	HTTX, has prompted the pharmaceutical company Roche to license the drug and take it forward.
1:21.1	Chris spoke with UCL researcher Ed Wilde, one of the team testing this new agent.
1:26.0	For the first time we have the results of a clinical trial that is aimed at tackling the cause of Huntington's disease, which is a protein called
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Dr Chris Smith, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Dr Chris Smith and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.